Traditional Chinese medicine for treating chronic pulmonary heart disease

Abstract

The invention relates to a traditional Chinese medicine for treating the chronic pulmonary heart disease and belongs to the technical field of traditional Chinese medicines. The invention adopts the technical scheme that the traditional Chinese medicine for treating the chronic pulmonary heart disease comprises the following raw materials in parts by weight: 20 to 30 parts of radix pseudostellariae, 10 to 15 parts of rhizoma polygonati, 20 to 30 parts of codonopsis pilosula, 10 to 15 parts of ligusticum wallichii, 10 to 15 parts of bighead atractylodes rhizome, 10 to 15 parts of radix paeoniae rubra, 10 to 15 parts of poria cocos, 5 to 10 parts of processed radix aconiti lateralis, 10 to 15 parts of semen lepidii, 5 to 10 parts of leech, 5 to 10 parts of cassia twig, 3 to 9 parts of ginger, 10 to 15 parts of plantain seed (wrap-boiled), 10 to 15 parts of platycodon grandiflorum and 10 to 15 parts of rhizoma alismatis. The traditional Chinese medicine for treating the chronic pulmonary heart disease is decocted with water and is taken for three times and a dose of the traditional Chinese medicine is taken every day. All raw materials of the traditional Chinese medicine disclosed by the invention can effectively treat the disease causes of the chronic pulmonary heart disease, play the respective effects, can complement mutually and take the effects of dissipating phlegm to relieve asthma, activating blood and benefiting qi, protecting myocardium and reinforcing the myocardial function.

Description

technical field [0001] The invention relates to a traditional Chinese medicine for treating chronic pulmonary heart disease, which belongs to the field of traditional Chinese medicine. Background technique [0002] Chronic cor pulmonale (referred to as cor pulmonale) is a disease in which pulmonary circulatory resistance increases and pulmonary hypertension is caused by chronic lesions of the lung, thorax or pulmonary artery, which in turn causes right ventricular hypertrophy and enlargement, and even develops into right heart failure. Clinically, it is characterized by repeated coughing, wheezing, expectoration, edema, and cyanosis. It can be divided into two aspects: compensation and decompensation. The age of onset is more than 40 years old. The disease exists all year round, and acute attacks are more common in winter and spring. Most of the links in the course of cor pulmonale are reversible. With appropriate treatment, the heart function can be recovered to a certai...

AI Technical Summary

Problems solved by technology

At present, there is no specific drug for the treatment of cor pulmonale. Most of them are treated with anti-inflammatory, cough, asthma or heart disease drugs, but the effect is not ideal, and the recurrence is very easy and the mortality rate is high.

Images